Drug General Information |
Drug ID |
DXXL3Z
|
Drug Name |
3-Phenyl-3H-benzoimidazol-5-ol
|
Synonyms |
CHEMBL153106
|
Indication |
Discovery agent
|
Investigative |
[1]
|
Formula |
C13H10N2O
|
Canonical SMILES |
Oc1ccc2ncn(c3ccccc3)c2c1
|
InChI |
InChI=1S/C13H10N2O/c16-11-6-7-12-13(8-11)15(9-14-12)10-4-2-1-3-5-10/h1-9,16H
|
InChIKey |
HJCXAWFZVAQPQN-UHFFFAOYSA-N
|
Target and Pathway |
Target(s) |
Basic fibroblast growth factor receptor 1 |
Target Info |
|
[1]
|
Platelet-derived growth factor receptor |
Target Info |
|
[1]
|
KEGG Pathway
|
MAPK signaling pathway
|
Ras signaling pathway
|
Rap1 signaling pathway
|
PI3K-Akt signaling pathway
|
Adherens junction
|
Signaling pathways regulating pluripotency of stem cells
|
Regulation of actin cytoskeleton
|
Pathways in cancer
|
Proteoglycans in cancer
|
Prostate cancer
|
Melanoma
|
Central carbon metabolism in cancer
|
NetPath Pathway
|
TCR Signaling Pathway
|
PANTHER Pathway
|
Angiogenesis
|
FGF signaling pathway
|
Pathway Interaction Database
|
Glypican 1 network
|
Syndecan-4-mediated signaling events
|
N-cadherin signaling events
|
FGF signaling pathway
|
WikiPathways
|
Regulation of Actin Cytoskeleton
|
Endochondral Ossification
|
MAPK Signaling Pathway
|
Mesodermal Commitment Pathway
|
Hair Follicle Development: Induction (Part 1 of 3)
|
Integrated Pancreatic Cancer Pathway
|
Signaling Pathways in Glioblastoma
|
Neural Crest Differentiation
|
Signaling by FGFR
|
References |
REF 1 | URL: https://www.ebi.ac.uk/chembl/ The ChEMBL database in 2017 |